NRx Pharmaceuticals, Lotus Pharmaceuticals and Alvogen Inc. Announce Collaboration to Develop and Commercialize NRX-101 - Yahoo Finance

Submitted by Anonymous (not verified) on Mon, 06/05/2023 - 11:00

NRx Pharmaceuticals, Lotus Pharmaceuticals and Alvogen Inc. Announce Collaboration to Develop and Commercialize NRX-101  Yahoo Finance